These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2890239)

  • 1. DNA-cytophotometry of benign compound and intradermal naevi, Spitz epithelioid naevi and malignant melanomas.
    Lindholm C; Bjelkenkrantz K; Hofer PA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(4):257-8. PubMed ID: 2890239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful differentiation of Spitz naevus from malignant melanoma by microfluorometric analysis of cellular DNA content.
    Otsuka F; Chi HI; Umebayashi Y
    Clin Exp Dermatol; 1993 Sep; 18(5):421-4. PubMed ID: 8252762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
    Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
    J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
    van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
    J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions.
    Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU
    Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological demarcation of lateral borders: an unsupportable criterion for distinguishing malignant melanoma from Spitz naevus and compound naevus.
    Okun MR
    Histopathology; 1998 Aug; 33(2):158-62. PubMed ID: 9762549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caryometry of benign compound acquired naevi, Spitz epitheloid naevi and malignant melanomas.
    Lindholm C; Hofer PA
    Acta Pathol Microbiol Immunol Scand A; 1986 Nov; 94(6):371-4. PubMed ID: 3811918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
    Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
    Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of spitzoid tumours: A clinical study.
    Hafiji J; Rytina E; Burrows NP
    Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile.
    Orchard DC; Dowling JP; Kelly JW
    Australas J Dermatol; 1997 Feb; 38(1):12-4. PubMed ID: 9046646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three patients with a Spitz naevus that later turned out to be a melanoma].
    Bron JL; Jaspars EH; Molenkamp BG; Meijer S; Mooi WJ; van Leeuwen PA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1852-8. PubMed ID: 16128184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
    Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
    Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
    Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
    Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.
    Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F
    J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
    MacKie RM; White SI; Seywright MM; Young H
    Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
    Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
    Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spitz naevi and malignant melanomas of childhood and adolescence.
    Peters MS; Goellner JR
    Histopathology; 1986 Dec; 10(12):1289-302. PubMed ID: 3817764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spitz naevi may express components of the plasminogen activation system.
    Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ
    J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
    Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
    Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can HLA-DR expression help in the routine diagnosis of malignant melanomas?
    West KP; Priyakumar P; Jagjivan R; Colloby PS
    Br J Dermatol; 1989 Aug; 121(2):175-8. PubMed ID: 2775642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.